Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients

Summary

This is a prospective single center, randomized, double-blind, 2 arm placebo-controlled study in subjects with Parkinson's disease receiving levodopa .The patients will be randomized to receive tablet Folic Acid 10 mg per day or placebo for 8 weeks. The safety and efficacy outcome measures will be assessed at baseline and 8 weeks.

Timeline

Start

2023-04-16

Primary completion

2024-07-16

Completion

2024-07-16

Drugs

Indications